Donglin Wang

Ying Cheng, R. Guo, Yiping Zhang, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Ef ﬁ cacy and Safety of SH-1028 in Patients With EGFR T790M-Positive NSCLC: A Multicenter, Single-Arm, Open-Label, Phase 2 Trial

Lei Wang, Xueqin Chen, Wei Li, 2022 .

Ef ﬁ cacy and Safety of Befotertinib (D-0316) in Patients With EGFR T790M-Mutated NSCLC That Had Progressed After Prior EGFR Tyrosine Kinase Inhibitor Therapy: A Phase 2, Multicenter, Single-Arm, Open-Label Study

Ying Cheng, R. Guo, Yiping Zhang, 2022 .

Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic/recurrent NSCLC patients with EGFR mutation from a phase I/IIa study

T. Wang, Yanqiu Zhao, Jianying Zhou, 2023, BMC Medicine.

Efficacy and safety of third-line treatment with anlotinib in patients with refractory advanced non-small-cell lung cancer (ALTER-0303): a randomised, double-blind, placebo-controlled phase 3 study

B. Han, K. Nan, Jianxing He, 2017 .

Efficacy and Safety of Apatinib in the Treatment of Postoperative Recurrence of Fibrosarcoma

Donglin Wang, Huiwen Ma, Xing-yue Chen, 2020, OncoTargets and therapy.

Inhibition of Hes1 enhances lapatinib sensitivity in gastric cancer sphere-forming cells

Huiqing Yu, Donglin Wang, Dairong Li, 2017, Oncology letters.

Circular RNA MYLK Promotes Glycolysis and Proliferation of Non-Small Cell Lung Cancer Cells by Sponging miR-195-5p and Increasing Glucose Transporter Member 3 Expression

Shuangyi Lei, Donglin Wang, Dairong Li, 2020, Cancer management and research.

On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial

Ying Cheng, R. Guo, Sheng Hu, 2022, Molecular cancer.

Capn4 promotes epithelial-mesenchymal transition in human melanoma cells through activation of the Wnt/β-catenin pathway.

Donglin Wang, Huiwen Ma, Shao-lin Li, 2017, Oncology reports.

HIF1α and HIF2α regulate non-small-cell lung cancer dedifferentiation via expression of Sox2 and Oct4 under hypoxic conditions.

Shuangyi Lei, Donglin Wang, Dairong Li, 2023, Gene.

The effect of icotinib combined with chemotherapy in untreated non-small-cell lung cancer that harbored EGFR-sensitive mutations in a real-life setting: a retrospective analysis

Donglin Wang, Dan Yang, Zhijuan Wu, 2018, OncoTargets and therapy.

miR-223 functions as a potent tumor suppressor of the Lewis lung carcinoma cell line by targeting insulin-like growth factor-1 receptor and cyclin-dependent kinase 2

Yi Huang, Donglin Wang, Yongzhong Wu, 2013, Oncology letters.

Silencing of ataxia-telangiectasia mutated by siRNA enhances the in vitro and in vivo radiosensitivity of glioma.

Ying Wang, F. Jin, Donglin Wang, 2016, Oncology reports.

Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies.

T. Wang, D. Zhong, Yanqiu Zhao, 2023, Lung cancer.

Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial Study

R. Guo, Yiping Zhang, Wei Zhang, 2022 .

Safety, Efficacy and Pharmacokinetics of Rezivertinib (BPI-7711) in Advanced Non-Small Cell Lung Cancer Patients with EGFR T790M Mutation: a Phase 1 Dose-Escalation and Dose-Expansion Study.

Yanqiu Zhao, Y. Shu, Gong-yan Chen, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Efficacy and safety of SH-1028 in patients with EGFR T790M positive non-small-cell lung cancer: a multicenter, single-arm, open-label, phase 2 trial.

Xueqin Chen, L. Xing, S. Ren, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Sensitivity of non-small cell lung cancer to erlotinib is regulated by the Notch/miR-223/FBXW7 pathway

Donglin Wang, Yongzhong Wu, Weiqi Nian, 2017, Bioscience reports.

Silencing of ATM expression by siRNA technique contributes to glioma stem cell radiosensitivity in vitro and in vivo.

Huiqing Yu, Donglin Wang, Dairong Li, 2017, Oncology reports.

Pleural effusion as a substitute for tumor tissue in detecting EGFR/ALK mutations in non-small cell lung cancer

Donglin Wang, J. Qin, Yongchun Shen, 2019, Medicine.

Maintenance Versus Intermittent Strategies in the Treatment of Metastatic Colorectal Cancer: A Meta-Analysis from Another Angle

Donglin Wang, Dairong Li, Caishuang Pang, 2019, Advances in Therapy.

Overexpression of centrosomal protein 55 regulates the proliferation of glioma cell and mediates proliferation promoted by EGFRvIII in glioblastoma U251 cells.

Changling Huang, S. Lv, Donglin Wang, 2017, Oncology letters.

Role of Kruppel-like factor 4 in regulating inhibitor of apoptosis-stimulating protein of p53 in the progression of gastric cancer

Huiqing Yu, Donglin Wang, Yongzhong Wu, 2018, Oncology letters.

Pembrolizumab plus chemotherapy for advanced non-small-cell lung cancer without tumor PD-L1 expression in Asia.

Jie Yang, M. Pietanza, He-long Zhang, 2023, Immunotherapy.

Efficacy and safety of befotertinib (D-0316) in patients with EGFR T790M mutated non-small cell lung cancer that had progressed after prior EGFR TKI therapy: A phase 2, multicenter, single-arm, open-label study.

Qingshan Li, Ying Cheng, R. Guo, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.